Since p16 could not be used as a positive control for NSCLC lines with homozygously deleted or unmethylated p16, we used the universally methylated gene transketolase-like 1 (TKTL1) as a positive control for loss of DNA methylation and gene induction. The gene discussed is CDKN2A; the disease is non-small cell lung carcinoma.